Related Experiment Video
Updated: May 5, 2026
11:13
Author Spotlight: Exploring Salidroside's Molecular Mechanisms in Breast Cancer Treatment
Published on: June 9, 2023
2.3K
IRP2 regulates breast tumor growth
Wei Wang1, Zhiyong Deng, Heather Hatcher
1Authors' Affiliations: Departments of Pathology, Cancer Biology, and Biostatistical Sciences, Wake Forest School of Medicine, Winston-Salem, North Carolina; Departments of Molecular, Microbial and Structural Biology and Internal Medicine, University of Connecticut Health Center, Farmington, Connecticut.
Cancer Research
|November 29, 2013
Summary
Iron regulatory protein 2 (IRP2) drives iron accumulation in breast cancer. Reducing IRP2 hinders cancer cell growth, suggesting IRP2 as a therapeutic target for iron-related cancers.
Area of Science:
- Oncology
- Molecular Biology
- Biochemistry
Background:
- Altered iron metabolism is implicated in cancer development.
- Mechanisms of iron dysregulation in cancer cells are under investigation.
Purpose of the Study:
- To investigate the role of iron regulatory protein 2 (IRP2) in breast cancer iron metabolism and growth.
- To determine the association between IRP2 expression and breast cancer subtypes and grade.
Main Methods:
- Investigated IRP2 and IRP1 expression in breast cancer.
- Performed IRP2 knockdown in MDA-MB-231 cells to assess effects on iron parameters and cell growth.
- Analyzed gene expression microarray data from breast cancer patients.
Main Results:
- IRP2 overexpression, not IRP1, correlates with decreased ferritin H and increased transferrin receptor 1 (TfR1) in breast cancer.
- IRP2 knockdown in MDA-MB-231 cells reduced the labile iron pool and inhibited tumor growth in vivo.
- Increased IRP2 expression is linked to high-grade breast cancer and observed across luminal and basal subtypes, but not ERBB2 subtype.
Conclusions:
- IRP2 dysregulation is a key factor in altered iron metabolism in breast cancer.
- IRP2 plays a significant role in breast cancer cell proliferation and iron accumulation.
- IRP2 may serve as a prognostic marker and therapeutic target for specific breast cancer subtypes.
Related Concept Videos
03:03mTOR Signaling and Cancer Progression
3.6K
The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
The mTOR pathway or the...
3.6K
02:23Abnormal Proliferation
4.0K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.0K
01:22PI3K/mTOR/AKT Signaling Pathway
5.2K
The mammalian target of rapamycin (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1 (mTORC1) and mTOR complex 2 (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast, mTORC2 consists of a...
5.2K
01:31Regulation of the Unfolded Protein Response
2.2K
Inositol-requiring kinase one or IRE1 is the most conserved eukaryotic unfolded protein response (UPR) receptor. It is a type I transmembrane protein kinase receptor with a distinctive site-specific RNase activity. As the binding mechanics of the misfolded proteins with the N-terminal domain of IRE-1 are unclear, three binding models — direct, indirect, and allosteric -- are proposed for receptor activation. Nevertheless, it is known that once a misfolded protein associates with IRE1, it...
2.2K
01:20The Retinoblastoma Gene
3.7K
Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
3.7K
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
8.3K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
8.3K